Dose reduction of biological treatment in patients with axial spondyloarthritis in clinical remission: Are there any differences between patients who relapsed and to those who remained in low disease activity?

@article{Almirall2015DoseRO,
  title={Dose reduction of biological treatment in patients with axial spondyloarthritis in clinical remission: Are there any differences between patients who relapsed and to those who remained in low disease activity?},
  author={M. Pilar Garc{\'i}a Almirall and Tarek Carlos Salman-Monte and Mar{\'i}a Pilar Lisbona and Joan Bala{\~n}{\`a} i Maym{\'o}},
  journal={Rheumatology International},
  year={2015},
  volume={35},
  pages={1565-1568}
}
The aim of the study was to assess whether dose reduction of biological treatment in patients with axial spondyloarthritis in sustained remission could be effective to maintain remission or low disease activity at 1 year and to explore baseline differences between patients who remained in remission or low disease activity and patients who relapsed. This was a prospective, observational study. All consecutive patients with axial spondyloarthritis in sustained remission were included and received… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Tables and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

  • J Sieper, D van der Heijde, M Dougados, PJ Mease, WP Maksymowych, MA Brown
  • Ann Rheum Dis
  • 2013

A double - blind , placebo - controlled trial of low dose infliximab in ankylosing spondylitis

  • RD Inman, WP Maskymowych
  • J Rheumatol
  • 2010

Maskymowych WP (2010) A double-blind, placebocontrolled trial of low dose infliximab in ankylosing spondylitis

  • RD Inman
  • J Rheumatol
  • 2010

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

  • D Van der Heijde, A Kivitz, MH Schiff, J Sieper, BA Dijkmans, J Braun
  • Arthritis Rheum
  • 2006

Similar Papers

Loading similar papers…